首药控股股价涨5.15%，国泰基金旗下1只基金重仓，持有2.62万股浮盈赚取4.68万元

Group 1 - The core point of the news is that Shouyao Holdings experienced a stock price increase of 5.15%, reaching 36.53 yuan per share, with a total market capitalization of 5.433 billion yuan as of the report date [1] - Shouyao Holdings, established on April 19, 2016, and listed on March 23, 2022, is primarily engaged in the research and development of small molecule anti-tumor drugs, with 100% of its revenue coming from technology development and services [1] Group 2 - From the perspective of major fund holdings, Guotai Fund has a significant position in Shouyao Holdings through its fund Guotai Innovation Medical Mixed Initiation A (018159), which held 26,200 shares, accounting for 4.77% of the fund's net value, ranking as the eighth largest holding [2] - The fund Guotai Innovation Medical Mixed Initiation A was established on April 18, 2023, with a latest scale of 17.7778 million yuan and has achieved a year-to-date return of 38.09%, ranking 2210 out of 8155 in its category [2] - The fund manager, Qiu Xiaoxu, has a tenure of 3 years and 144 days, with the fund's total asset size at 676 million yuan, achieving a best return of 5.58% and a worst return of 0.5% during the tenure [2]